We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$131M
AUM Growth
+$6.73M
Cap. Flow
+$5.72M
Cap. Flow %
4.38%
Top 10 Hldgs %
28.35%
Holding
135
New
27
Increased
31
Reduced
39
Closed
22
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.8 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$9.2M
2
ALLK icon
Allakos
ALLK
+$3.62M
3
TSM icon
TSMC
TSM
+$1.56M
4
LKQ icon
LKQ Corp
LKQ
+$1.2M
5
DBX icon
Dropbox
DBX
+$1M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$2.37M
2
HOLX icon
Hologic
HOLX
+$1.35M
3
TWTR
Twitter, Inc.
TWTR
+$1.34M
4
BAX icon
Baxter International
BAX
+$1.29M
5
CNC icon
Centene
CNC
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 53.84%
2 Technology 17.83%
3 Miscellaneous 14.77%
4 Communication Services 7.12%
5 Consumer Discretionary 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NTGN
1
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$5.84M 4.47%
832,355
+829,833
+32,904% +$9.2M
2018 Q2
1 quarter
CI icon
2
CALL
Cigna
CI
$79.5B
$5.77M 4.42%
+27,700
New +$5.14M
2018 Q3
0 quarters
UBX icon
3
DELISTED
Unity Biotechnology
UBX
$4.48M 3.43%
30,873
-3
-0% -$494
2018 Q2
1 quarter
ALLK icon
4
DELISTED
Allakos
ALLK
$3.54M 2.72%
+88,125
New +$3.62M
2018 Q3
0 quarters
IHI icon
5
PUT
iShares US Medical Devices ETF
IHI
$3.72B
$3.41M 2.61%
+90,000
New +$3.2M
2018 Q3
0 quarters
ALNA
6
DELISTED
Allena Pharmaceuticals
ALNA
$3.24M 2.48%
301,889
+3,884
+1% +$42.7K
2017 Q4
3 quarters
ELV icon
7
Elevance Health
ELV
$93B
$2.85M 2.18%
10,405
-3,939
-27% -$1.02M
2016 Q4
7 quarters
GOOGL icon
8
Alphabet (Google) Class A
GOOGL
$4.17T
$2.77M 2.12%
45,920
-1,560
-3% -$94.4K
2017 Q2
5 quarters
IWM icon
9
PUT
iShares Russell 2000 ETF
IWM
$76B
$2.56M 1.96%
15,200
-12,600
-45% -$2.13M
2018 Q2
1 quarter
VTRS icon
10
Viatris
VTRS
$21.1B
$2.54M 1.95%
69,449
-430
-0.6% -$16.1K
2018 Q1
2 quarters
GDDY icon
11
GoDaddy
GDDY
$13.3B
$2.41M 1.84%
28,856
+3,203
+12% +$250K
2016 Q4
7 quarters
INTU icon
12
Intuit
INTU
$86.1B
$2.39M 1.83%
10,522
+2,633
+33% +$566K
2018 Q1
2 quarters
JAZZ icon
13
Jazz Pharmaceuticals
JAZZ
$13.6B
$2.36M 1.81%
14,027
-3,307
-19% -$569K
2018 Q1
2 quarters
CRM icon
14
Salesforce
CRM
$197B
$2.25M 1.72%
14,134
-5,019
-26% -$745K
2017 Q2
5 quarters
HUM icon
15
Humana
HUM
$50.1B
$2.25M 1.72%
6,634
+449
+7% +$146K
2016 Q3
8 quarters
DBX icon
16
Dropbox
DBX
$7.67B
$2.02M 1.55%
75,287
+34,684
+85% +$1M
2018 Q1
2 quarters
DATA
17
DELISTED
Tableau Software, Inc.
DATA
$1.93M 1.47%
17,226
+1,426
+9% +$154K
2018 Q1
2 quarters
SPOT icon
18
Spotify
SPOT
$107B
$1.91M 1.46%
10,542
+1,378
+15% +$253K
2018 Q2
1 quarter
ZBH icon
19
Zimmer Biomet
ZBH
$18B
$1.88M 1.44%
14,745
-2,980
-17% -$354K
2017 Q4
3 quarters
MSGS icon
20
Madison Square Garden
MSGS
$9.38B
$1.83M 1.4%
8,148
+2,327
+40% +$517K
2018 Q2
1 quarter
EW icon
21
Edwards Lifesciences
EW
$49.7B
$1.77M 1.36%
30,573
+21
+0.1% +$1.03K
2014 Q4
15 quarters
ABT icon
22
Abbott
ABT
$181B
$1.75M 1.34%
23,925
-3,109
-12% -$204K
2017 Q2
5 quarters
A icon
23
Agilent Technologies
A
$48.6B
$1.72M 1.32%
24,367
+2,029
+9% +$134K
2018 Q1
2 quarters
AMZN icon
24
Amazon
AMZN
$2.68T
$1.68M 1.28%
16,740
+1,080
+7% +$102K
2017 Q2
5 quarters
AAPL icon
25
Apple
AAPL
$5T
$1.67M 1.28%
29,600
+17,292
+140% +$901K
2018 Q2
1 quarter

Similar funds

Partner Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, Partner Investment Management held 135 positions worth $131M, up 5.4% from $124M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Partner Investment Management deployed $5.72M of net new capital in Q3 2018, opening 27 new positions and adding to 31 existing holdings. Its largest new stake was Allakos: 88,125 shares worth $3.54M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 51% a quarter earlier, followed by Technology and Miscellaneous.

On the sell side, the largest reduction was Elevance Health, an estimated $1.02M trimmed.

  • Partner Investment Management's largest Q3 2018 buy was Allakos: 88,125 shares worth $3.54M.
  • Partner Investment Management added most to Neon Therapeutics, Inc. Common Stock in Q3 2018, an estimated $9.2M increase.
  • Partner Investment Management's biggest Q3 2018 reduction was Elevance Health, cutting an estimated $1.02M.
  • Partner Investment Management fully exited Baidu in Q3 2018, selling an estimated $2.37M.
  • Partner Investment Management's ten largest holdings make up 28% of its $131M portfolio in Q3 2018.
  • Partner Investment Management opened 27 new positions and closed 22 in Q3 2018.
  • Partner Investment Management's portfolio value rose 5.4% quarter-over-quarter to $131M.

Based on Partner Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.